Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome

Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome

Andrey E Dorofeyev1, Elena A Kiriyan2, Inna V Vasilenko1, Olga A Rassokhina1, Andrey F Elin11National Medical University, Donetsk, Ukraine; 2Gastroenterological Center of Poltava Hospital Clinic, Poltava, UkraineObjectives: The aim of this study was to analyze the clinical efficacy and cytomorpholog...

Full description

Bibliographic Details
Main Authors:	Dorofeyev AE, Kiriyan EA, Vasilenko IV, Rassokhina OA, Elin AF
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-06-01
Series:	Clinical and Experimental Gastroenterology
Online Access:	http://www.dovepress.com/clinical-endoscopical-and-morphological-efficacy-of-mesalazine-in-pati-a7665

Similar Items

Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine
by: Mauro Bafutto, et al.
Published: (2011-03-01)

The Effect of Mesalazine on Pain Management in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
by: M Khosravi, et al.
Published: (2022-03-01)

Morphological manifestations of irritable bowel syndrome
by: Yu.M. Stepanov, et al.
Published: (2021-06-01)

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial
by: Ching Lam, et al.
Published: (2015-03-01)

Efficacy of Peppermint Oil in Irritable Bowel Syndrome
by: Suhasini Dehury, et al.
Published: (2022-06-01)

Irritable bowel syndrome: epidemiological and pathogenetic aspects
by: Tikhonova Т.А., et al.
Published: (2018-03-01)

Biological Therapy of Crohn’s Disease in Ukraine
by: A.E. Dorofeyev, et al.
Published: (2014-02-01)

The irritable bowel syndrome
by: Vaerenbergh Wim, et al.
Published: (1998-01-01)

Irritable Bowel Syndrome
by: Jae Hak Kim, et al.
Published: (2019-02-01)

Irritable bowel syndrome
by: Vasile Valeriu LUPU, et al.
Published: (2016-03-01)

Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome
by: V V Tsukanov, et al.
Published: (2016-08-01)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Özdener AE, et al.
Published: (2017-09-01)

Irritable bowel syndrome as a biopsychosocial disease (review)
by: Kozlova I.V., et al.
Published: (2012-06-01)

Evaluation of the Impact of Some Single-Nucleotide Gene Polymorphisms on the Development of Adenomatous Polyps of the Colon in Patients with Irritable Bowel Syndrome
by: Olena Kyrian, et al.
Published: (2023-08-01)

Efficacy of the Rome criteria II in diagnosis of irritable bowel syndrome
by: A I Parfenov, et al.
Published: (2004-04-01)

Understanding irritable bowel syndrome /
by: 262617 Darnley, Simon, et al.
Published: (2003)

Irritable Bowel Syndrome and Resilience
by: Mihaela Fadgyas Stanculete, et al.
Published: (2023-06-01)

IRRITATED BOWEL SYNDROME IN CHILDREN
by: V. F. Privorotskiy, et al.
Published: (2012-05-01)

Postinfection irritable bowel syndrome
by: A I Papfenov, et al.
Published: (2009-02-01)

Diets and Irritable Bowel Syndrome
by: Zahra Darabi, et al.
Published: (2019-09-01)

The epidemiology of irritable bowel syndrome
by: Canavan C, et al.
Published: (2014-02-01)

Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial
by: Mohammad Reza Ghadir, et al.
Published: (2017-01-01)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
by: Xiufang Cui, et al.
Published: (2021-11-01)

Efficacy of mesalazine at ulcerative colitis with nutritional failure
by: A. V. Korolyov, et al.
Published: (2024-03-01)

Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder.
by: Chia-Jen Liu, et al.
Published: (2015-01-01)

Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
by: Satohiro Matsumoto, et al.
Published: (2020-12-01)

Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial
by: Sergii Tkach, et al.
Published: (2022-10-01)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
by: Jaroslaw Daniluk, et al.
Published: (2022-02-01)

Unique strain of Bifidobacterium longum and its efficacy in irritable bowel syndrome
by: E. Yu. Plotnikova
Published: (2021-01-01)

Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis
by: Pere Clavé, et al.
Published: (2017-03-01)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
by: Kathleen Van Malderen, et al.
Published: (2020-04-01)

Disentangling psychopathology and irritable bowel syndrome
by: Martin, M, et al.
Published: (2012)

Food intolerance and the irritable bowel syndrome.
by: Nanda, R, et al.
Published: (1989)

Asian consensus on irritable bowel syndrome
by: Gwee, Kok-Ann, et al.
Published: (2010)

Postinfectious irritable bowel syndrome in children
by: D.V. Pechkurov, et al.
Published: (2021-09-01)

Effect of Diet on Irritable Bowel Syndrome
by: Seung Han Kim
Published: (2022-05-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

Irritable Bowel Syndrome: The role of the Psychiatry
by: A. Fraga, et al.
Published: (2022-06-01)

An Asian perspective on irritable bowel syndrome
by: Kee Wook Jung, et al.
Published: (2023-04-01)

Impact of Gluten on Irritable Bowel Syndrome
by: Sana Uruj, et al.
Published: (2023-08-01)